ROCHESTER, Minn. — A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may ...

New York-based Tyme Technologies partnered with Rochester, Minn.-based Mayo Clinic to launch a pancreatic research program. Here’s what you need to know. 1. Martin Fernandez-Zapico, MD, will lead the ...

The Sandler-Kenner Foundation has announced it will give Mayo Clinic in Rochester, Minn., a $500,000, multi-year donation to help fund a study of the early detection of pancreatic cancer. The ...

Pancreatic cancer often hides in plain sight. Many of its earliest warnings look like everyday problems. A stubborn bout of indigestion, or a new backache that will not settle. A strange change in ...

Researchers have reported that a blood-based panel combining four protein biomarkers has shown strong ability to detect early-stage pancreatic ductal adenocarcinoma, outperforming the commonly ...

Pancreatic cancer incidence has increased, largely due to obesity, diet, and sedentary lifestyles, with traditional risk factors playing a lesser role. Advances in targeted therapies, especially those ...

Mayo Clinic has announced plans to build proton beam therapy facilities at its Rochester, Minn., and Scottsdale, Ariz., cancer center sites, a combined $370 million project, according to a Mayo Clinic ...